Dissemin is shutting down on January 1st, 2025

Published in

Wiley, Clinical Genetics, 6(77), p. 525-534, 2010

DOI: 10.1111/j.1399-0004.2010.01436.x

Oxford University Press, Nucleic Acids Research, D1(45), p. D865-D876, 2016

DOI: 10.1093/nar/gkw1039

Links

Tools

Export citation

Search in Google Scholar

The Human Phenotype Ontology in 2017.

Journal article published in 2016 by Sebastian Köhler, Nicole A. Vasilevsky ORCID, Mark Engelstad, Erin Foster, Julie McMurry ORCID, Ségolène Aymé, Gareth Baynam, Susan M. Bello, Cornelius F. Boerkoel, Kym M. Boycott, Bert B. A. de Vries, Michael Brudno, Orion J. Buske, Patrick F. Chinnery, Valentina Cipriani and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Deep phenotyping has been defined as the precise and comprehensive analysis of phenotypic abnormalities in which the individual components of the phenotype are observed and described. The three components of the Human Phenotype Ontology (HPO; www.human-phenotype-ontology.org) project are the phenotype vocabulary, disease-phenotype annotations and the algorithms that operate on these. These components are being used for computational deep phenotyping and precision medicine as well as integration of clinical data into translational research. The HPO is being increasingly adopted as a standard for phenotypic abnormalities by diverse groups such as international rare disease organizations, registries, clinical labs, biomedical resources, and clinical software tools and will thereby contribute toward nascent efforts at global data exchange for identifying disease etiologies. This update article reviews the progress of the HPO project since the debut Nucleic Acids Research database article in 2014, including specific areas of expansion such as common (complex) disease, new algorithms for phenotype driven genomic discovery and diagnostics, integration of cross-species mapping efforts with the Mammalian Phenotype Ontology, an improved quality control pipeline, and the addition of patient-friendly terminology. Nucleic Acids Res 2017 Jan 4; 45(D1):D865-D876.